Celiac disease. Celiac disease
Conditions
Interventions
Intervention 1: Intervention group: 52 patients with celiac disease will be included in this group
Patients will receive probiotic medicine for three months, along with routine medicines, and at the end of the study, their quality of life score will be checked. Intervention 2: Control group: 52 pat
Patients will receive a placebo for three months, along with routine drugs, and at the end of the study, their quality of life score will be checked.
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients with celiac disease confirmed by celiac biopsy Patients whose disease is not controlled with a gluten-free diet
Exclusion criteria
Exclusion criteria: Patients with diabetes History of antibiotic use in the last three months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: The beginning of the study and three months later (the end of the study). Method of measurement: CDAT quality of life questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Molaei
Tabriz University of Medical Sciences
Outcome results
None listed